Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
6.15
+0.26 (4.41%)
At close: Mar 9, 2026, 4:00 PM EDT
6.15
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:02 PM EDT
Atea Pharmaceuticals Market Cap
Atea Pharmaceuticals has a market cap or net worth of $490.78 million as of March 9, 2026. Its market cap has increased by 85.05% in one year.
Market Cap
490.78M
Enterprise Value
180.23M
1-Year Change
85.05%
Ranking
Category
Stock Price
$6.15
Market Cap Chart
Since the IPO on October 30, 2020, Atea Pharmaceuticals's market cap has decreased from $1.94B to $490.78M, a decrease of -74.67%. That is a compound annual growth rate of -22.64%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zevra Therapeutics | 508.93M |
| Contineum Therapeutics | 507.93M |
| enGene Holdings | 507.11M |
| CorMedix | 505.92M |
| Vanda Pharmaceuticals | 493.55M |
| Altimmune | 490.36M |
| Century Therapeutics | 487.74M |
| Kyverna Therapeutics | 484.46M |